Edesa Biotech, Inc.: Boxer Capital Management, LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Boxer Capital Management disclosed a stake exceeding 5% in Edesa Biotech in a Schedule 13G filing with the SEC (accession 0001213900-26-120702). The exact share count and percentage were not specified in the filing headline. The move signals activist or strategic interest in the clinical-stage biotech. Investors will watch for further disclosures detailing the size and intent of the position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Boxer Capital Management, LLC, Edesa Biotech, Inc.